Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HPV16 is a small double-stranded DNA virus that infects mucosal epithelial cells via specific cell surface receptors. It causes a significant proportion of anogenital and head-and-neck cancers worldwide due to its potent oncogenic proteins E6/E7 that disrupt normal cell cycle control mechanisms. Vaccination remains the most effective preventive measure against diseases caused by this virus.
Vaccines stimulate an immune response to prevent infection.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human papillomavirus type 16 (HPV16).